SOIKEN HOLDINGS INC
TSE
2385

2385
SOIKEN HOLDINGS INC
TSE
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

2385 Stock Chart

Take your trading to the next level Start free trial

Financials

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Employees: 101
Soiken Holdings Inc. engages in the development of biomarkers and assessment systems. Its operates through the following segments: Evaluation and Testing Biomarker Development, Pharmaceutical Clinical Research Support, Healthcare Support, Cosmetics, Dietary Supplements, and Functional Material Development. The Evaluation and Testing Biomarker Development segment performs clinical evaluation tests on the function and safety of food. It also does clinical research support of pharmaceutical products. The Healthcare Support segment offers services on health guidance and health insurance. The Cosmetics segment produces and sells cosmetics. The Dietary Supplements segment sells health supplements that include Imida Peptide. The Functional Material Development segment develops and sales functional materials that include lactoferrin. The company was founded by Osami Kajimoto in July 1994 and is headquartered in Osaka, Japan.

News

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Refer a friend My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out